I am Chu-Wen Lin, PhD, An Associate Professor and Associate Dean in the Department of Histology and Embryology at the School of Medicine, Sun Yat-sen University, China. Upon injuries, the lung can undergo swift repair and regeneration, thereby restoring normal lung function. Any disturbances in the development and regeneration of the lung epithelium can lead to neonatal mortality or serious respiratory conditions, including pulmonary fibrosis, chronic obstructive pulmonary disease, and lung cancer. These conditions represent significant clinical challenges and pose serious risks to human health, often being nearly impossible to cure. Our research team has developed mouse models for studying lung regeneration, utilizing a combination of mouse genetics, three-dimensional alveolar stem cell culture methods, and single-cell sequencing to explore the mechanisms governing the proliferation and differentiation of lung stem cells during lung injury repair. We investigate the underlying causes and biological targets of common lung diseases such as lung cancer, pulmonary fibrosis, and chronic obstructive pulmonary disease, with a focus on targeted drug development. Through a multidisciplinary approach that encompasses mouse genetics, cell biology, sequencing, and organ culture, we are investigating the mechanisms of lung diseases, and identifying new therapeutic targets. I have published 12 articles as the first author or co-corresponding author in important academic SCI journals such as Genes & Development and Life. My first-author articles have been cited over 700 times in SCI journals, including Nature, Cell, and Science. I was invited to give speeches at the 9th International Conference of Developmental Biology in 2019 and the 2021 meeting of the Respiratory Physicians Branch of the Chinese Medical Association. In total, the papers I published have been cited more than 2,000 times. My Google Scholar's H-index is 15. I have peer reviewed over 40 manuscripts for academic journals including Nature, Developmental Cell, and Acta Pharmacological Sinica. We are aiming to employ a combination of animal models and human stem cell models in order to translate our basic research findings into a better understanding of the fundamental mechanisms contributing to lung diseases such as Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease (COPD). I'm good at critical thinking, and possess strong active listening, communication, interpersonal, leadership, mentoring, management, and problem-solving skills to effectively oversee the editorial process and maintain high publication standards. Additionally, they must have a solid background in biomedical sciences and familiarity with publishing ethics and digital tools to critically evaluate research and guide authors and reviewers. I like playing tennis and biking.